Clinical trial
Exploring the Impact of Nephropathy Formula No. 1 on T-Cell Immune Balance in Chronic Kidney Disease Patients Via the IL-6/STAT3 Signaling Pathway
NCT06796660 is registered in ClinicalTrials.gov with Liu Zhanghong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Impact of Nephropathy Formula No. 1 on T-Cell Immune Balance in Chronic Kidney Disease Patients Via the IL-6/STAT3 Signaling Pathway
- Lead sponsor
- Liu Zhanghong
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.